Structure Therapeutics Inc. – NASDAQ:GPCR

Structure Therapeutics stock price today

$18.92
-10.11
-34.85%
Financial Health
0
1
2
3
4
5
6
7
8
9

Structure Therapeutics stock price monthly change

-33.82%
month

Structure Therapeutics stock price quarterly change

-33.82%
quarter

Structure Therapeutics stock price yearly change

-20.00%
year

Structure Therapeutics key metrics

Market Cap
1.59B
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-2.32
Revenue
N/A
EBITDA
-114.99M
Income
-97.84M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Structure Therapeutics stock price history

Structure Therapeutics stock forecast

Structure Therapeutics financial statements

Structure Therapeutics Inc. (NASDAQ:GPCR): Profit margin
Jun 2023 0 -23.28M
Sep 2023 0 -23.86M
Dec 2023 1.32M -24.67M -1855.04%
Mar 2024 0 -26.03M
Structure Therapeutics Inc. (NASDAQ:GPCR): Analyst Estimates
Mar 2024 0 -26.03M
Sep 2025 0 -13.45M
Oct 2025 0 -13.97M
Dec 2025 0 -15.21M
  • Analysts Price target

  • Financials & Ratios estimates

Structure Therapeutics Inc. (NASDAQ:GPCR): Earnings per share (EPS)
2023-11-14 -0.29 -0.62
2024-03-08 -0.21 -0.17
2024-05-09 -0.21 -0.19
Structure Therapeutics Inc. (NASDAQ:GPCR): Debt to assets
Jun 2023 229428000 15.01M 6.54%
Sep 2023 216370000 23.40M 10.82%
Dec 2023 482017096 29.05M 6.03%
Mar 2024 457220419 27.40M 5.99%
Structure Therapeutics Inc. (NASDAQ:GPCR): Cash Flow
Jun 2023 -16.89M -68.71M -297K
Sep 2023 -20.55M 30.12M 473K
Dec 2023 -21.90M -180.88M 281.97M
Mar 2024 -34.02M 1.41M 700.85K

Structure Therapeutics alternative data

Structure Therapeutics Inc. (NASDAQ:GPCR): Employee count
Aug 2023 68
Sep 2023 77
Oct 2023 77
Nov 2023 77
Dec 2023 87
Jan 2024 87
Feb 2024 87
Mar 2024 93
Apr 2024 93
May 2024 93
Jun 2024 93
Jul 2024 111

Structure Therapeutics other data

42.65% +42.65%
of GPCR is owned by hedge funds
3.86M +3.86M
shares is hold by hedge funds

Structure Therapeutics Inc. (NASDAQ:GPCR): Insider trades (number of shares)
Period Buy Sel
Oct 2023 0 17454
Dec 2023 0 17454
Feb 2024 0 525
Mar 2024 0 21997
Jun 2024 0 220400
Transaction Date Insider Security Shares Price per share Total value Source
Sale
STEVENS RAYMOND C director, officer: CHIEF EXECUT..
American Depositary Shares 185,000 N/A N/A
Sale
LIN XICHEN officer: CHIEF SCIENTIFIC OFFICER
American Depositary Shares 17,700 N/A N/A
Sale
LIN XICHEN officer: CHIEF SCIENTIFIC OFFICER
American Depositary Shares 17,700 N/A N/A
Option
LIN XICHEN officer: CHIEF SCIENTIFIC OFFICER
Share Option (right to buy) 106,200 $0.34 $36,108
Option
LIN XICHEN officer: CHIEF SCIENTIFIC OFFICER
Ordinary Shares 106,200 $0.34 $36,108
Sale
FMR LLC 10 percent owner, other: See Re..
American Depositary Shares 21,997 N/A N/A
Sale
FMR LLC 10 percent owner, other: See Re..
American Depositary Shares 525 N/A N/A
Sale
FMR LLC 10 percent owner
American Depositary Shares 16,086 N/A N/A
Sale
FMR LLC 10 percent owner
American Depositary Shares 1,368 N/A N/A
Sale
FMR LLC 10 percent owner
American Depositary Shares 16,086 N/A N/A
Tuesday, 17 December 2024
globenewswire.com
Thursday, 5 December 2024
youtube.com
Tuesday, 19 November 2024
benzinga.com
Friday, 15 November 2024
globenewswire.com
Wednesday, 13 November 2024
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Wednesday, 23 October 2024
zacks.com
Tuesday, 22 October 2024
seekingalpha.com
Wednesday, 9 October 2024
zacks.com
Tuesday, 17 September 2024
globenewswire.com
Thursday, 12 September 2024
247wallst.com
Tuesday, 27 August 2024
globenewswire.com
Monday, 26 August 2024
globenewswire.com
marketwatch.com
Tuesday, 13 August 2024
investorplace.com
Wednesday, 24 July 2024
zacks.com
Monday, 22 July 2024
fool.com
Friday, 12 July 2024
investorplace.com
Friday, 28 June 2024
investorplace.com
Monday, 17 June 2024
fool.com
Tuesday, 11 June 2024
youtube.com
zacks.com
fool.com
Sunday, 9 June 2024
fool.com
Friday, 7 June 2024
globenewswire.com
Wednesday, 5 June 2024
globenewswire.com
Tuesday, 4 June 2024
investorplace.com
Monday, 3 June 2024
youtube.com
globenewswire.com
investorplace.com
  • What's the price of Structure Therapeutics stock today?

    One share of Structure Therapeutics stock can currently be purchased for approximately $18.92.

  • When is Structure Therapeutics's next earnings date?

    Unfortunately, Structure Therapeutics's (GPCR) next earnings date is currently unknown.

  • Does Structure Therapeutics pay dividends?

    No, Structure Therapeutics does not pay dividends.

  • How much money does Structure Therapeutics make?

    Structure Therapeutics has a market capitalization of 1.59B. Structure Therapeutics made a loss 89.62M US dollars in net income (profit) last year or -$0.19 on an earnings per share basis.

  • What is Structure Therapeutics's stock symbol?

    Structure Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "GPCR".

  • What is Structure Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Structure Therapeutics?

    Shares of Structure Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Structure Therapeutics have?

    As Jul 2024, Structure Therapeutics employs 111 workers, which is 19% more then previous month and 19% more then previous quarter.

  • When Structure Therapeutics went public?

    Structure Therapeutics Inc. is publicly traded company for more then 2 years since IPO on 3 Feb 2023.

  • What is Structure Therapeutics's official website?

    The official website for Structure Therapeutics is structuretx.com.

  • Where are Structure Therapeutics's headquarters?

    Structure Therapeutics is headquartered at 611 Gateway Boulevard, South San Francisco, CA.

  • How can i contact Structure Therapeutics?

    Structure Therapeutics's mailing address is 611 Gateway Boulevard, South San Francisco, CA and company can be reached via phone at +62 82299277.

Structure Therapeutics company profile:

Structure Therapeutics Inc.

structuretx.com
Exchange:

NASDAQ

Full time employees:

136

Industry:

Biotechnology

Sector:

Healthcare

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

611 Gateway Boulevard
South San Francisco, CA 94080

CIK: 0001888886
ISIN: US86366E1064
CUSIP: 86366E106